CONMED Corp
- Stock
- Ticker CNMD
- ISIN US2074101013
- NYSE
Performance, volatility and drawdowns of CONMED Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $11,013. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −78.7% in 06/2026, measured from the peak in 11/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 09/2024 | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 317 | 346 | 321 | 342 | 338 | 373 | 343 | 336 |
| Gross profit | 179 | 198 | 178 | 188 | 166 | 218 | 197 | 189 |
| Operating income | 66 | 52 | 16 | 38 | 12 | 37 | 36 | 37 |
| EBITDA | 70 | 57 | 20 | 43 | 16 | 41 | – | 41 |
| Net income | 49 | 34 | 6.0 | 21 | 2.9 | 17 | 23 | 20 |
| Earnings per share | 1.57 | 1.08 | 0.19 | 0.69 | 0.09 | 0.54 | 0.77 | 0.66 |
| Balance sheet | ||||||||
| Total assets | 2,316 | 2,306 | 2,298 | 2,328 | 2,322 | 2,326 | 2,300 | 2,304 |
| Liabilities | 1,383 | 1,344 | 1,320 | 1,326 | 1,314 | 1,293 | 1,259 | 1,245 |
| Equity | 933 | 963 | 978 | 1,003 | 1,008 | 1,033 | 1,041 | 1,060 |
| Cash | 38 | 24 | 35 | 34 | 39 | 41 | 37 | 48 |
| Cash flow | ||||||||
| Operating cash flow | 51 | 43 | 42 | 29 | 54 | 46 | – | 49 |
| Capital expenditure | -3.4 | -4.0 | -3.8 | -5.7 | -5.2 | -5.1 | – | -2.7 |
| Free cash flow | 48 | 39 | 38 | 23 | 48 | 41 | – | 47 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2019 at +75.7%, weakest 2025 at −40.0%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 28 Oct 2026 | $0.66 |
| 29 Jul 2026 | $0.77 |
| 17 Feb 2026 | $0.54 |
| 6 Nov 2025 | $0.09 |
| 31 Jul 2025 | $0.69 |
| 1 May 2025 | $0.19 |
| 18 Feb 2025 | $1.08 |
| 31 Oct 2024 | $1.57 |
| 1 Aug 2024 | $0.96 |
| 25 Apr 2024 | $0.63 |
| 28 Feb 2024 | $1.05 |
| 26 Oct 2023 | $0.50 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.3bn
- Market cap in trading currency
- $1.39bn
- Enterprise value
- $1.34bn
- P/E
- –
- P/S
- –
- P/B
- 1.31
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- –
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- –
- Net income
- –
- Earnings per share
- –
- Revenue per share
- –
- Revenue growth
- −0.7%
- Earnings growth
- +592.4%
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- –
- Return on assets
- –
Balance sheet and cash flow
- Cash
- $48.0m
- Cash per share
- $1.61
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 1.49
- Book value per share
- $35.56
- Operating cash flow
- –
- Free cash flow
- –
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- 15 Sep 2025
Shares and trading
- Shares outstanding
- 29.8m
- Volume
- 384,262
- Avg. volume 3 months
- 362,049
- Relative volume
- 1.1
Price and technicals
- Price
- $46.56
- 1 day
- +0.4%
- 52-week high
- $53.66
- 52-week low
- $32.11
- Distance to 52-week high
- −13.2%
- Distance to 52-week low
- +45.0%
- Distance to 50-day line
- −1.4%
- Distance to 200-day line
- +10.6%
- RSI (14)
- 43
- Volatility 1M
- 56.7%
Performance
- 1 week
- −8.0%
- 1 month
- −5.8%
- 3 months
- −9.6%
- 6 months
- +25.1%
- YTD
- +14.7%
- 1 year
- +14.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has CNMD performed since 11/2016?
$10,000 grew to $11,013 by 20 Nov 2026, which is +1.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is CNMD?
Volatility was 36.7% per year, measured on monthly returns. The largest decline from a peak was −78.7%, with the low in 06/2026.
How does CNMD compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CNMD returned +1.0% at 36.7%. The correlation of monthly returns was 0.53; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.